Oura Ring 5 Puts Health Data in the Boardroom, But Can CEOs Afford the Privacy Hit?
The Oura Ring 5’s new FDA-cleared feature for detecting sleep apnea has analysts cheering, but the real C-suite concern isn’t medical. With real-time biometrics now streaming into corporate wellness dashboards, the $349 device creates a direct pipeline from employee physiology to HR metrics. Early adopters report a 22% rise in productivity scores, yet legal teams are flagging GDPR and HIPAA gray zones. The viral takeaway: Oura Ring 5 isn’t just wearable tech; it’s a strategic liability asset. CEOs who skip the privacy audit risk exposure bigger than any sleep deficit.